Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    ES15 - Is Cytotoxic Chemotherapy in NSCLC Management Only Palliative?

    • 15:45 - 16:45
    • 8/07/2022
    • Location: Strauss 1/2
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Metastatic Non-small Cell Lung Cancer - Palliative Chemotherapy
    • +

      ES15.05 - Second-Line Chemotherapy Following First-Line Mono-Immunotherapy in High PD-L1 (TPS≥50%) Advanced/Metastatic NSCLC

      16:04 - 16:16  |  Presenter: Sara Pilotto

      • Abstract

      Loading...

  • +

    EP02.04 - Early Stage Non-small Cell Lung Cancer - Systemic Therapy

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Early Stage Non-small Cell Lung Cancer - Systemic Therapy
    • +

      EP02.04-001 - Alectinib as Neoadjuvant Treatment in Surgically Resectable Stage III ALK-Positive NSCLC: ALNEO Phase II Trial (GOIRC-01-2020)

      Presenter: Alessandro Leonetti

      • Abstract

      Loading...

  • +

    EP05.01 - Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
    • +

      EP05.01-024 - Real-life Management of Stage III NSCLC Patients in Italy: The BE-PACIFIC Observational Study

      Presenter: Paolo Bironzo

      • Abstract

      Loading...

  • +

    EP06.01 - Management of Lung Cancer in the Era of COVID-19

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Management of Lung Cancer in the Era of COVID-19
    • +

      EP06.01-006 - Multidisciplinary Team during the COVID-19 Pandemic: The BE-PACIFIC Italian Observational Study Analysis.

      Presenter: Enrica Capelletto

      • Abstract

      Loading...

  • +

    EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
    • +

      EP08.01-030 - Nivolumab+Ipilimumab Vs Platinum-Based CT+Nivolumab In Advanced Lung Squamous-Cell Carcinoma: The Randomized SQUINT Trial

      Presenter: Federico Cappuzzo

      • Abstract

      Loading...

  • +

    EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      EP08.02-046 - Activity of OsimeRTInib in NSCLC with Uncommon EGFR Mutations: Retrospective Observational Multicenter Study (ARTICUNO)

      Presenter: Elio Gregory Pizzutilo

      • Abstract

      Loading...

    • +

      EP08.02-048 - Crizotinib in ROS1+NSCLC: Long-term OS Analysis in Patients with Brain Metastases Included in the Phase II METROS Trial

      Presenter: Federico Cappuzzo

      • Abstract

      Loading...

    • +

      EP08.02-104 - Osimertinib in Untreated EGFR-Mutant Non-small Cell Lung Cancers: Overall Survival and Budget Impact Analysis in Real-World

      Presenter: Martina Lorenzi

      • Abstract

      Loading...

  • +

    EP10.01 - Palliative and Supportive Care

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Palliative and Supportive Care
    • +

      EP10.01-011 - Prognostic Impact of Body Composition Phenotypes in Non-small Cell Lung Cancer Patients Receiving First-Line Pembrolizumab

      Presenter: Ilaria Trestini

      • Abstract

      Loading...

  • +

    EP16.03 - Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
    • +

      EP16.03-040 - Biomarkersatlas.com: the Italian NSCLC Precision Medicine Knowledge Data Base

      Presenter: Umberto Malapelle

      • Abstract

      Loading...

  • +

    P1.12 - Management of Lung Cancer in the Era of COVID-19

    • 17:00 - 19:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Management of Lung Cancer in the Era of COVID-19
    • +

      P1.12-04 - The FLARE score and circulating neutrophils are associated with poor Covid-19 outcomes in patients with thoracic cancers

      Presenter: Laura Mezquita

      • Abstract

      Loading...